Emerald Clinical Appoints Luke Gill as Vice President, Global Head of Oncology, Medical & Scientific Affairs
- Written by PR Newswire
![]() |
Accomplished biotech and CRO leader brings 25+ years of global oncology drug development and operational excellence to propel Emerald's continued growth.
SINGAPORE, Dec. 3, 2025 /PRNewswire/ -- Emerald Clinical Trials, a leading global clinical research organization (CRO), today announced the appointment of Luke Gill, MSc, MBA, as Vice...














